Insights

Strategic Licensing Braingaze has an active licensing partnership with Tris Pharma initiated in 2024 to develop and distribute digital diagnostic and therapeutic products for ADHD and other neurological conditions, signaling potential for co-selling, co-development, and channel leverage in pharma and medical device markets.

Clinical Validation Solutions are already used in leading clinics for cognitive disorder management, backed by an international, interdisciplinary team, suggesting strong clinical credibility to prospects and opportunities to expand adoption in hospital networks and specialty clinics.

Narrow Focus, Global Reach Despite a small team, Braingaze operates with global partnerships and a patented eye movement biomarker, enabling targeted outreach to neurology, psychiatry, pediatrics, and aging research segments across regions seeking innovative digital health tools.

Funding & Growth Recent funding and accelerator exposure through PepsiCo Greenhouse indicate investor interest and growth momentum, providing a narrative for engaging strategic investors or partners who value validated digital health startups with food and beverage or wellness sector synergies.

Product Expansion Past launches of ADHD diagnostic and therapeutic software across multiple platforms (Android, iOS, Windows tablets) show a track record of product agility and potential for further platform-enabled solutions, remapping opportunities in telehealth, early diagnosis programs, and cognitive health monitoring contracts.

Similar companies to Braingaze

Braingaze Tech Stack

Braingaze uses 8 technology products and services including Trident AB, Cloudflare CDN, WordPress, and more. Explore Braingaze's tech stack below.

  • Trident AB
    A/B Testing
  • Cloudflare CDN
    Content Delivery Network
  • Content Management System
  • Infrastructure As A Service
  • Next.js
    Javascript Frameworks
  • Platform As A Service
  • YouTube
    Video Players

Braingaze's Email Address Formats

Braingaze uses at least 1 email format:
Braingaze Email FormatsExamplePercentage
First@braingaze.comJohn@braingaze.com
100%

Frequently Asked Questions

What is Braingaze's official website and social media links?

Minus sign iconPlus sign icon
Braingaze's official website is braingaze.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Braingaze generate?

Minus sign iconPlus sign icon
As of October 2026, Braingaze's annual revenue is estimated to be <$1M.

What is Braingaze's NAICS code?

Minus sign iconPlus sign icon
Braingaze's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Braingaze have currently?

Minus sign iconPlus sign icon
As of October 2026, Braingaze has approximately 7 employees across 1 continents, including Europe. Key team members include Co-Founder And Ceo: L. B. and Co-Founder & Cto: H. S. Explore Braingaze's employee directory with LeadIQ.

What industry does Braingaze belong to?

Minus sign iconPlus sign icon
Braingaze operates in the Medical Equipment Manufacturing industry.

What technology does Braingaze use?

Minus sign iconPlus sign icon
Braingaze's tech stack includes Trident AB, Cloudflare CDN, WordPress, Microsoft 365, Google Cloud, Next.js, Vercel and YouTube.

What is Braingaze's email format?

Minus sign iconPlus sign icon
Braingaze's email format typically follows the pattern of First@braingaze.com. Find more Braingaze email formats with LeadIQ.

How much funding has Braingaze raised to date?

Minus sign iconPlus sign icon
As of October 2026, Braingaze has raised $1.6M in funding. The last funding round occurred on Mar 06, 2024 for $1.6M.

When was Braingaze founded?

Minus sign iconPlus sign icon
Braingaze was founded in 2013.
Braingaze logo

Braingaze

Medical Equipment ManufacturingCatalonia, Spain2-10 Employees

Braingaze is a medical equipment manufacturing company based in Mataro, Catalonia, Spain, with a small staff of 2 to 10 employees. The company develops digital health solutions to detect, diagnose and treat cognitive disorders such as ADHD and Alzheimer's disease, using eye movement cognitive vergence as a marker of cognitive processing, a method that has worldwide patent protection. It operates with an international, interdisciplinary team of scientists, mathematicians and AI experts, product developers and entrepreneurs. Historical milestones include the 2018 launch of software to help diagnose ADHD and the 2020 release of an ADHD therapy app for Android, iOS and Windows tablets. In 2024, Braingaze entered licensing and partnership arrangements with Tris Pharma and established Tris Digital Health, while past financing and collaboration activity includes a PepsiCo Greenhouse Accelerator funding event in 2021.

Section iconCompany Overview

NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2013
Employees
2-10

Section iconFunding & Financials

  • $1.6M

    Braingaze has raised a total of $1.6M of funding over 4 rounds. Their latest funding round was raised on Mar 06, 2024 in the amount of $1.6M as a Venture Round.

  • <$1M

    Braingaze's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.